December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Primary Intraocular and Central Nervous System Lymphomas: Correlation Between Proliferating Cell Nuclear Antigen (PCNA) and DNA Flow Cytometry
Author Affiliations & Notes
  • M Silveira
    Ophthalmology Universidade do Estado do Rio de Janeiro Rio de Janeiro Brazil
  • T Martinu
    Ophthalmology The Henry C Witelson Eye Pathology Laboratory McGill University Montreal PQ Canada
  • PM Ozdal
    Ophthalmology The Henry C Witelson Eye Pathology Laboratory McGill University Montreal PQ Canada
  • SA Callejo
    Ophthalmology The Henry C Witelson Eye Pathology Laboratory McGill University Montreal PQ Canada
  • AL Caissie
    Ophthalmology The Henry C Witelson Eye Pathology Laboratory McGill University Montreal PQ Canada
  • MN Burnier
    Ophthalmology The Henry C Witelson Eye Pathology Laboratory McGill University Montreal PQ Canada
  • Footnotes
    Commercial Relationships   M. Silveira, None; T. Martinu, None; P.M. Ozdal, None; S.A. Callejo, None; A.L. Caissie, None; M.N. Burnier, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2584. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Silveira, T Martinu, PM Ozdal, SA Callejo, AL Caissie, MN Burnier; Primary Intraocular and Central Nervous System Lymphomas: Correlation Between Proliferating Cell Nuclear Antigen (PCNA) and DNA Flow Cytometry . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2584.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Primary intraocular lymphoma (PIOL) and CNS lymphoma (CNSL) are lethal neoplasms classified as extra-nodal large B-cell lymphomas. The five-year survival rate is 3-4% among treated patients. The purpose of this study is to characterize the immune-expression of PCNA in both PIOL and CNSL, and to correlate it with DNA Flow Cytometry in an effort to explain the aggressive behavior of these tumors. Methods: Eleven formalin-fixed, paraffin-embedded specimens, representing 4 PIOL and 7 CNSL, were immunostained with a monoclonal antibody against PCNA. A PCNA grading system of 0, + and ++ was applied to evaluate the intensity of the immunostain. Furthermore the percentage of PCNA stained cells was determined in ten high power fields and recorded as low (less than 30%), medium (from 30 to 70%), and high (more than 70%). All specimens were analyzed using DNA Flow Cytometry to measure the S-phase fraction (SPF) of the tumors. Mitotic figures were counted in ten high power fields. Results: All eleven specimens were PCNA positive. There was no difference in the degree of staining between the two groups. All of them had areas with + and ++ staining. In the CNSL group there were 2 cases with high number of PCNA positive cells (70%), 3 with medium (50%) and 2 with low (20 -30%). In the PIOL group 3 cases were graded as high (70% and 90%) and 1 as medium (40%). The SPF average was higher in the PIOL group (25.2 %) than in the CNSL group (15,8%) .The highest number of mitotic figures was found in the highest SPF tumor. This CNSL was also recorded as high PCNA. Conclusions: PCNA correlates with the SPF of both primary intraocular and CNS lymphomas and is therefore a useful immune marker of proliferation activity of neoplastic cells in these malignancies. PCNA activity represents a reliable indicator of the aggressive behavior of these lymphomas.

Keywords: 434 immunohistochemistry • 413 flow cytometry • 508 pathology techniques 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×